107 related articles for article (PubMed ID: 7504518)
1. Mapping of the 19p13 breakpoint in an ovarian carcinoma between the INSR and TCF3 loci.
Aman P; Pejovic T; Wennborg A; Heim S; Mitelman F
Genes Chromosomes Cancer; 1993 Oct; 8(2):134-6. PubMed ID: 7504518
[TBL] [Abstract][Full Text] [Related]
2. Linkage relationships of the insulin receptor gene with the complement component 3, LDL receptor, apolipoprotein C2 and myotonic dystrophy loci on chromosome 19.
Shaw DJ; Meredith AL; Brook JD; Sarfarzi M; Harley HG; Huson SM; Bell GI; Harper PS
Hum Genet; 1986 Nov; 74(3):267-9. PubMed ID: 2877934
[TBL] [Abstract][Full Text] [Related]
3. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
Amfo K; Neyns B; Teugels E; Lissens W; Bourgain C; De Sutter P; Vandamme B; Vamos E; De Grève J
Oncogene; 1995 Jul; 11(2):351-8. PubMed ID: 7624149
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.
Barber KE; Harrison CJ; Broadfield ZJ; Stewart AR; Wright SL; Martineau M; Strefford JC; Moorman AV
Genes Chromosomes Cancer; 2007 May; 46(5):478-86. PubMed ID: 17311319
[TBL] [Abstract][Full Text] [Related]
5. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma.
Thompson FH; Taetle R; Trent JM; Liu Y; Massey-Brown K; Scott KM; Weinstein RS; Emerson JC; Alberts DS; Nelson MA
Cancer Genet Cytogenet; 1997 Jul; 96(2):106-10. PubMed ID: 9216715
[TBL] [Abstract][Full Text] [Related]
6. Mapping of translocation breakpoints on the short arm of chromosome 19 in acute leukemias by in situ hybridization.
Saltman DL; Mellentin JD; Smith SD; Cleary ML
Genes Chromosomes Cancer; 1990 Nov; 2(4):259-65. PubMed ID: 2268576
[TBL] [Abstract][Full Text] [Related]
7. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map.
Micci F; Weimer J; Haugom L; Skotheim RI; Grunewald R; Abeler VM; Silins I; Lothe RA; Trope CG; Arnold N; Heim S
Genes Chromosomes Cancer; 2009 Feb; 48(2):184-93. PubMed ID: 18973136
[TBL] [Abstract][Full Text] [Related]
8. Association of a RFLP for the insulin receptor gene, but not insulin, with essential hypertension.
Ying LH; Zee RY; Griffiths LR; Morris BJ
Biochem Biophys Res Commun; 1991 Nov; 181(1):486-92. PubMed ID: 1683535
[TBL] [Abstract][Full Text] [Related]
9. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
10. Frequent translocations of 11q13.2 and 19p13.2 in ovarian cancer.
Wang L; Wenners A; Hilpert F; Fredrik R; Micci F; Onkes W; Caliebe A; Maass N; Weimer J; Arnold N
Genes Chromosomes Cancer; 2014 Jun; 53(6):447-53. PubMed ID: 24615723
[TBL] [Abstract][Full Text] [Related]
11. Molecular investigation of 19p13 in standard and variant translocations: the E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotype.
Yamada T; Craig JM; Hawkins JM; Janossy G; Secker-Walker LM
Leukemia; 1991 Jan; 5(1):36-40. PubMed ID: 1999956
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
Foulkes WD; Ragoussis J; Stamp GW; Allan GJ; Trowsdale J
Br J Cancer; 1993 Mar; 67(3):551-9. PubMed ID: 8094976
[TBL] [Abstract][Full Text] [Related]
13. The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2.
Martinerie C; Cannizzaro LA; Croce CM; Huebner K; Katzav S; Barbacid M
Hum Genet; 1990 Nov; 86(1):65-8. PubMed ID: 2253939
[TBL] [Abstract][Full Text] [Related]
14. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.
Aberle H; Bierkamp C; Torchard D; Serova O; Wagner T; Natt E; Wirsching J; Heidkämper C; Montagna M; Lynch HT
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6384-8. PubMed ID: 7604000
[TBL] [Abstract][Full Text] [Related]
15. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.
Mellentin JD; Murre C; Donlon TA; McCaw PS; Smith SD; Carroll AJ; McDonald ME; Baltimore D; Cleary ML
Science; 1989 Oct; 246(4928):379-82. PubMed ID: 2799390
[TBL] [Abstract][Full Text] [Related]
16. Whole chromosome 17 loss in ovarian cancer.
Tavassoli M; Ruhrberg C; Beaumont V; Reynolds K; Kirkham N; Collins WP; Farzaneh F
Genes Chromosomes Cancer; 1993 Nov; 8(3):195-8. PubMed ID: 7509629
[TBL] [Abstract][Full Text] [Related]
17. A hypervariable region at the D19S11 locus.
Buroker NE; Bufton L; Surti U; Leppert M; Kumlin E; Sheehy R; Magenis RE; Litt M
Hum Genet; 1987 May; 76(1):90-5. PubMed ID: 2883111
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
[TBL] [Abstract][Full Text] [Related]
19. Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas.
Pejovic T; Heim S; Mandahl N; Elmfors B; Flodérus UM; Furgyik S; Helm G; Willén H; Mitelman F
Genes Chromosomes Cancer; 1989 Nov; 1(2):167-71. PubMed ID: 2487157
[TBL] [Abstract][Full Text] [Related]
20. Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism.
Suliman SG; Stanik J; McCulloch LJ; Wilson N; Edghill EL; Misovicova N; Gasperikova D; Sandrikova V; Elliott KS; Barak L; Ellard S; Volpi EV; Klimes I; Gloyn AL
Diabetes; 2009 Dec; 58(12):2954-61. PubMed ID: 19720790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
